***Background.*** Neonatal infections result in significant morbidity, mortality and increased health care costs. Antibiotics are commonly prescribed to infants hospitalized in the Neonatal Intensive Care Unit (NICU). Broad spectrum antibiotic exposure has been associated with emergence of resistant organisms and disruption in the development of normal flora. There is paucity of data evaluating the appropriateness of antibiotic use in the NICU, based on Centers for Disease Control and Prevention (CDC) 12-Step Guidelines to Prevent Antimicrobial Resistance.

***Methods.*** A retrospective audit of antibiotic use at a tertiary perinatal centre covering four million population was conducted during July 2010 -- June 2013. Our objective was to assess the practice of antibiotic therapy for compliance to the recommendations of the CDC 12-step campaign.

***Results.*** We audited vancomycin, meropenem and linezolid use in the NICU. Empirical use \>3-day without appropriate specimens collected, or utilization despite narrower spectrum antibiotic available, were considered inappropriate use.

  Agent        CDC 12-step violation                                                                                      Inappropriate use examples
  ------------ ---------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------
  Meropenem    4                                                                                                          Continued use despite organism is sensitive to 3^rd^ generation cephalosporins
  9            Prolonged empirical use without collecting appropriate specimens / redundant coverage with metronidazole   
  Vancomycin   4                                                                                                          Treatment for ampicillin-sensitive (amp-S) Enterococcus or methicillin-sensitive Staphylococcus aureus (MSSA)
  9            Prolonged empirical use without collecting appropriate specimens                                           
  Linezolid    4                                                                                                          Treatment for (amp-S) Enterococcus or MSSA or Enterobacteriaceae

  Agent        Antibiotic Courses   Duration (Median days, IQR)   Antibiotic Days   Proportion of Inappropriate Prescription
  ------------ -------------------- ----------------------------- ----------------- ------------------------------------------
  Meropenem    57                   3 \[7, 14\]                   525               10/57 (17.5%)
  Vancomycin   133                  7 \[5, 11\]                   1204              48/133 (36.0%)
  Linezolid    35                   7 \[3,9\]                     233               6/35 (17.1%)

***Conclusion.*** The CDC 12-Step Campaign is feasible in the NICU setting. Inappropriate antibiotic prescriptions are not uncommon in relation to the use of meropenem, vancomycin and linezolid. Attention should be focused on timely streamlining of these antimicrobials and collection of appropriate microbiologic specimens.
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